# Employers Holdings, Inc.: financial statements, quarterly

EIG · NYSE · CIK 1379041 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eig.md) · [Financials](/companies/eig/financials.md) · [Filings](/companies/eig/filings.md) · [Insiders](/companies/eig/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eig/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [204](/filings/0001379041-24-000166.md) | [226 d](/filings/0001379041-26-000011.md) | [223](/filings/0001379041-25-000097.md) | [217](/filings/0001379041-25-000137.md) | [224](/filings/0001379041-25-000146.md) | [217 d](/filings/0001379041-26-000011.md) | [203](/filings/0001379041-26-000023.md) | [246](/filings/0001379041-26-000061.md) | [239](/filings/0001379041-25-000146.md) | [171 d](/filings/0001379041-26-000011.md) | [208](/filings/0001379041-26-000023.md) | [220](/filings/0001379041-26-000061.md) |
| Interest expense | $m | [1.0](/filings/0001379041-23-000133.md) | [0.6 d](/filings/0001379041-24-000042.md) | [0.0](/filings/0001379041-24-000104.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.4](/filings/0001379041-24-000166.md) | [12.5 d](/filings/0001379041-26-000011.md) | [7.0](/filings/0001379041-25-000097.md) | [8.3](/filings/0001379041-25-000137.md) | [6.4](/filings/0001379041-25-000146.md) | [6.3 d](/filings/0001379041-26-000011.md) | [3.1](/filings/0001379041-26-000023.md) | [7.3](/filings/0001379041-26-000061.md) | [(2.9)](/filings/0001379041-25-000146.md) | [(6.2) d](/filings/0001379041-26-000011.md) | [2.6](/filings/0001379041-26-000023.md) | [5.6](/filings/0001379041-26-000061.md) |
| Net income | $m | [14.0](/filings/0001379041-24-000166.md) | [45.6 d](/filings/0001379041-26-000011.md) | [28.3](/filings/0001379041-25-000097.md) | [31.7](/filings/0001379041-25-000137.md) | [30.3](/filings/0001379041-25-000146.md) | [28.3 d](/filings/0001379041-26-000011.md) | [12.8](/filings/0001379041-26-000023.md) | [29.7](/filings/0001379041-26-000061.md) | [(8.3)](/filings/0001379041-25-000146.md) | [(23.4) d](/filings/0001379041-26-000011.md) | [10.2](/filings/0001379041-26-000023.md) | [29.1](/filings/0001379041-26-000061.md) |
| Diluted EPS | $ per share | [0.54](/filings/0001379041-24-000166.md) | not reported | [1.11](/filings/0001379041-25-000097.md) | [1.25](/filings/0001379041-25-000137.md) | [1.21](/filings/0001379041-25-000146.md) | not reported | [0.52](/filings/0001379041-26-000023.md) | [1.23](/filings/0001379041-26-000061.md) | [(0.36)](/filings/0001379041-25-000146.md) | not reported | [0.52](/filings/0001379041-26-000023.md) | [1.59](/filings/0001379041-26-000061.md) |
| Basic EPS | $ per share | [0.54](/filings/0001379041-24-000166.md) | not reported | [1.12](/filings/0001379041-25-000097.md) | [1.25](/filings/0001379041-25-000137.md) | [1.22](/filings/0001379041-25-000146.md) | not reported | [0.52](/filings/0001379041-26-000023.md) | [1.24](/filings/0001379041-26-000061.md) | [(0.36)](/filings/0001379041-25-000146.md) | not reported | [0.53](/filings/0001379041-26-000023.md) | [1.60](/filings/0001379041-26-000061.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [109](/filings/0001379041-23-000133.md) | [226](/filings/0001379041-25-000049.md) | [114](/filings/0001379041-24-000104.md) | [95.5](/filings/0001379041-24-000146.md) | [143](/filings/0001379041-24-000166.md) | [68.3](/filings/0001379041-26-000011.md) | [100](/filings/0001379041-25-000097.md) | [69.1](/filings/0001379041-25-000137.md) | [167](/filings/0001379041-25-000146.md) | [160](/filings/0001379041-26-000061.md) | [153](/filings/0001379041-26-000023.md) | [113](/filings/0001379041-26-000061.md) |
| Total assets | $m | [3,527](/filings/0001379041-23-000133.md) | [3,550](/filings/0001379041-25-000049.md) | [3,563](/filings/0001379041-24-000104.md) | [3,550](/filings/0001379041-24-000146.md) | [3,617](/filings/0001379041-24-000166.md) | [3,541](/filings/0001379041-26-000011.md) | [3,557](/filings/0001379041-25-000097.md) | [3,543](/filings/0001379041-25-000137.md) | [3,526](/filings/0001379041-25-000146.md) | [3,437](/filings/0001379041-26-000061.md) | [3,437](/filings/0001379041-26-000023.md) | [3,380](/filings/0001379041-26-000061.md) |
| Total liabilities | $m | [2,608](/filings/0001379041-23-000133.md) | [2,537](/filings/0001379041-25-000049.md) | [2,544](/filings/0001379041-24-000104.md) | [2,527](/filings/0001379041-24-000146.md) | [2,524](/filings/0001379041-24-000166.md) | [2,473](/filings/0001379041-26-000011.md) | [2,481](/filings/0001379041-25-000097.md) | [2,460](/filings/0001379041-25-000137.md) | [2,487](/filings/0001379041-25-000146.md) | [2,481](/filings/0001379041-26-000061.md) | [2,570](/filings/0001379041-26-000023.md) | [2,522](/filings/0001379041-26-000061.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001379041-26-000011.md) | not reported | not reported | not reported | [19.0](/filings/0001379041-26-000061.md) | [125](/filings/0001379041-26-000023.md) | [125](/filings/0001379041-26-000061.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001379041-26-000011.md) | not reported | not reported | not reported | [16.0](/filings/0001379041-26-000061.md) | [0.0](/filings/0001379041-26-000023.md) | [0.0](/filings/0001379041-26-000061.md) |
| Shareholders' equity | $m | [919](/filings/0001379041-24-000166.md) | [1,014](/filings/0001379041-26-000011.md) | [1,019](/filings/0001379041-25-000137.md) | [1,023](/filings/0001379041-25-000146.md) | [1,093](/filings/0001379041-25-000146.md) | [1,069](/filings/0001379041-26-000061.md) | [1,076](/filings/0001379041-26-000061.md) | [1,083](/filings/0001379041-26-000061.md) | [1,039](/filings/0001379041-25-000146.md) | [956](/filings/0001379041-26-000061.md) | [867](/filings/0001379041-26-000061.md) | [859](/filings/0001379041-26-000061.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [25.3 d](/filings/0001379041-24-000166.md) | [27.6 d](/filings/0001379041-26-000011.md) | [0.6](/filings/0001379041-25-000097.md) | [11.7 d](/filings/0001379041-25-000137.md) | [51.0 d](/filings/0001379041-25-000146.md) | [13.1 d](/filings/0001379041-26-000011.md) | [14.6](/filings/0001379041-26-000023.md) | [0.0 d](/filings/0001379041-26-000061.md) | [29.4 d](/filings/0001379041-25-000146.md) | [0.7 d](/filings/0001379041-26-000011.md) | [2.2](/filings/0001379041-26-000023.md) | [(10.3) d](/filings/0001379041-26-000061.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [7.3 d](/filings/0001379041-24-000166.md) | [7.2 d](/filings/0001379041-26-000011.md) | [7.8](/filings/0001379041-25-000097.md) | [7.6 d](/filings/0001379041-25-000137.md) | [7.4 d](/filings/0001379041-25-000146.md) | [7.5 d](/filings/0001379041-26-000011.md) | [7.5](/filings/0001379041-26-000023.md) | [7.9 d](/filings/0001379041-26-000061.md) | [7.4 d](/filings/0001379041-25-000146.md) | [7.1 d](/filings/0001379041-26-000011.md) | [6.3](/filings/0001379041-26-000023.md) | [6.3 d](/filings/0001379041-26-000061.md) |
| Share repurchases | $m | [15.4 d](/filings/0001379041-24-000166.md) | [14.6 d](/filings/0001379041-26-000011.md) | [5.6](/filings/0001379041-25-000097.md) | [18.8 d](/filings/0001379041-25-000137.md) | [7.6 d](/filings/0001379041-25-000146.md) | [10.6 d](/filings/0001379041-26-000011.md) | [19.8](/filings/0001379041-26-000023.md) | [23.5 d](/filings/0001379041-26-000061.md) | [45.4 d](/filings/0001379041-25-000146.md) | [94.1 d](/filings/0001379041-26-000011.md) | [79.3](/filings/0001379041-26-000023.md) | [30.2 d](/filings/0001379041-26-000061.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q1 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [27.4](/filings/0001379041-23-000133.md) | [27.4](/filings/0001379041-24-000104.md) | [26.8](/filings/0001379041-24-000146.md) | [26.1](/filings/0001379041-24-000166.md) | [25.5](/filings/0001379041-25-000097.md) | [25.4](/filings/0001379041-25-000137.md) | [25.0](/filings/0001379041-25-000146.md) | [24.6](/filings/0001379041-26-000023.md) | [24.1](/filings/0001379041-26-000061.md) | [23.4](/filings/0001379041-25-000146.md) | [19.5](/filings/0001379041-26-000023.md) | [18.3](/filings/0001379041-26-000061.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 17,960,506 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001379041-26-000061.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. No prices; not investment advice.